Literature DB >> 14525917

Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss.

Hongbing He1, Rongkun Liu, Tesfahun Desta, Cataldo Leone, Louis C Gerstenfeld, Dana T Graves.   

Abstract

The most common cause of inflammatory bone loss is periodontal disease. After bacterial insult, inflammation induces bone resorption, which is followed by new reparative bone formation. Because diabetics have a higher incidence and more severe periodontitis, we examined mechanisms by which diabetes alters the response of bone to bacterial challenge. This was accomplished with db/db mice, which naturally develop type 2 diabetes. After inoculation of bacteria osteoclastogenesis and bone resorption was measured. Both parameters were decreased in the diabetic group. Diabetes also suppressed reparative bone formation measured histologically and by the expression of osteocalcin. The impact of diabetes on new bone formation coincided with the effect of diabetes on apoptosis of bone-lining cells. Within 5 d of bacterial challenge, apoptosis declined in the wild-type animals yet remained significantly higher in the diabetic group. Thus, diabetes may cause a net loss of bone because the suppression of bone formation is greater than the suppression of bone resorption. The uncoupling of bone formation and resorption may be due in part to prolonged apoptosis of bone lining cells.

Entities:  

Mesh:

Year:  2003        PMID: 14525917     DOI: 10.1210/en.2003-1239

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

Review 1.  Animal models to study host-bacteria interactions involved in periodontitis.

Authors:  Dana T Graves; Jun Kang; Oelisoa Andriankaja; Keisuke Wada; Carlos Rossa
Journal:  Front Oral Biol       Date:  2011-11-11

2.  The effects of low-level laser irradiation on bone tissue in diabetic rats.

Authors:  Tatiane Lopes Patrocínio-Silva; André Moreira Fogaça de Souza; Raul Loppi Goulart; Carolina Fuirini Pegorari; Jussan Rodrigues Oliveira; Kelly Fernandes; Angela Magri; Rosa Maria Rodrigues Pereira; Daniel Ribeiro Araki; Márcia Regina Nagaoka; Nivaldo Antônio Parizotto; Ana Cláudia Muniz Rennó
Journal:  Lasers Med Sci       Date:  2013-08-29       Impact factor: 3.161

3.  Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Authors:  Meghan A Piccinin; Zia A Khan
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

4.  Osteoclasts in bone regeneration under type 2 diabetes mellitus.

Authors:  Zhiai Hu; Chi Ma; Yongxi Liang; Shujuan Zou; Xiaohua Liu
Journal:  Acta Biomater       Date:  2018-11-30       Impact factor: 8.947

5.  Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation.

Authors:  R Liu; H S Bal; T Desta; N Krothapalli; M Alyassi; Q Luan; D T Graves
Journal:  J Dent Res       Date:  2006-06       Impact factor: 6.116

Review 6.  Immune cells link obesity-associated type 2 diabetes and periodontitis.

Authors:  M Zhu; B S Nikolajczyk
Journal:  J Dent Res       Date:  2014-01-06       Impact factor: 6.116

7.  Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.

Authors:  Lindsay M Coe; Srinivasan Arjun Tekalur; Yutian Shu; Melissa J Baumann; Laura R McCabe
Journal:  J Cell Physiol       Date:  2015-08       Impact factor: 6.384

Review 8.  Rehabilitative considerations for dental implants in the diabetic patient.

Authors:  Preeti Agarwal Katyayan; Manish Katyayan; Rupal J Shah
Journal:  J Indian Prosthodont Soc       Date:  2012-11-01

Review 9.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

10.  Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen.

Authors:  Yugal Behl; Michelle Siqueira; Javier Ortiz; Jingchao Li; Tesfahun Desta; Dan Faibish; Dana T Graves
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.